4576 — D.Western Therapeutics Institute Cashflow Statement
0.000.00%
- ¥5bn
- ¥5bn
- ¥472m
Annual cashflow statement for D.Western Therapeutics Institute, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -290 | -160 | -440 | -827 | -1,289 |
Depreciation | |||||
Non-Cash Items | 30.7 | 2.98 | 159 | 49.4 | 93.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.57 | -64.8 | -120 | 142 | -154 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -216 | -176 | -355 | -587 | -1,299 |
Capital Expenditures | -5.13 | -2.9 | -9.81 | -14.9 | -10.1 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -8.34 | -108 | -130 | -0.316 | 0.12 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -13.5 | -111 | -140 | -15.3 | -10 |
Financing Cash Flow Items | — | -1.08 | -24.1 | -0.528 | -0.315 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1,004 | -104 | 867 | 134 | 568 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 767 | -374 | 401 | -467 | -741 |